Search research articles
Contact Us
Filters
Showing results (351-360 of 503) with videos related to
Page
of 51
Sort By:
Blood
|
June 27, 2012
A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515
Alison T Stopeck, Joseph M Unger, Lisa M Rimsza, et al.
Cancer
|
December 10, 2025
Disparities in clinical trial participation among older adult Medicare beneficiaries with hematologic malignancies from 2006 to 2019: A SEER-Medicare analysis
Inna Y Gong, Mark J Soto, Bahar Rafinejad-Farahani, et al.
Journal of the American College of Radiology : JACR
|
March 2, 2019
Lung Cancer Screening in the National Cancer Institute Community Oncology Research Program: Availability and Service Organization
Ruth C Carlos, JoRean D Sicks, Caroline Chiles, et al.
Neuroscience
|
October 9, 2017
Acylated and unacylated ghrelin confer neuroprotection to mesencephalic neurons
Johanna Wagner, Franca Vulinović, Anne Grünewald, et al.
Leukemia & Lymphoma
|
April 18, 2009
A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108
Alison T Stopeck, Joseph M Unger, Lisa M Rimsza, et al.
JCO Oncology Practice
|
October 4, 2021
Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials
David Hui, Amy K Darke, Katherine A Guthrie, et al.
Cancer Medicine
|
February 4, 2020
Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era
Michael E Roth, Joseph M Unger, Ann M O'Mara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2008
Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014
Daniel O Persky, Joseph M Unger, Catherine M Spier, et al.
Chest
|
March 27, 1998
Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy
S Lam, T Kennedy, M Unger, et al.
Molecular and Cellular Biochemistry
|
July 16, 2011
Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice
Janeen H Trembley, Gretchen M Unger, Diane K Tobolt, et al.
Page
of 51
Search research articles
Search
Showing results (351-360 of 503) with videos related to
Sort By:
Page
of 51
Blood
|
June 27, 2012
A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515
Alison T Stopeck, Joseph M Unger, Lisa M Rimsza, et al.
Cancer
|
December 10, 2025
Disparities in clinical trial participation among older adult Medicare beneficiaries with hematologic malignancies from 2006 to 2019: A SEER-Medicare analysis
Inna Y Gong, Mark J Soto, Bahar Rafinejad-Farahani, et al.
Journal of the American College of Radiology : JACR
|
March 2, 2019
Lung Cancer Screening in the National Cancer Institute Community Oncology Research Program: Availability and Service Organization
Ruth C Carlos, JoRean D Sicks, Caroline Chiles, et al.
Neuroscience
|
October 9, 2017
Acylated and unacylated ghrelin confer neuroprotection to mesencephalic neurons
Johanna Wagner, Franca Vulinović, Anne Grünewald, et al.
Leukemia & Lymphoma
|
April 18, 2009
A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108
Alison T Stopeck, Joseph M Unger, Lisa M Rimsza, et al.
JCO Oncology Practice
|
October 4, 2021
Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials
David Hui, Amy K Darke, Katherine A Guthrie, et al.
Cancer Medicine
|
February 4, 2020
Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era
Michael E Roth, Joseph M Unger, Ann M O'Mara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2008
Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014
Daniel O Persky, Joseph M Unger, Catherine M Spier, et al.
Chest
|
March 27, 1998
Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy
S Lam, T Kennedy, M Unger, et al.
Molecular and Cellular Biochemistry
|
July 16, 2011
Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice
Janeen H Trembley, Gretchen M Unger, Diane K Tobolt, et al.
Page
of 51